MMP-2 and MMP-9 activity, LDH, γGT and glucose levels were evaluated in bile at the end of reperfusion period. by Andrea Ferrigno (4779078)

The top ranked poisonous plants based on their LD50 and respondent scores. by Faisal Rasool (12530732)

Twelve anthropometric measurements of foot taken from 3D images [59]. by Liying Zhang (102453)

The S178A mutation in Paxillin decreases adhesion size and axial ratio. by Mathew E. Berginski (214153)

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

“…The optimal nanoparticle concentration reaches approximately 88.8% under high-load conditions, with each 3.55% increase in concentration resulting in a 0.45% reduction in structural deformation and a 0.59 nN decrease in friction. …”

Comparisons of corticospinal excitability between the SIS and comparison groups (mean ± SD). by Ya-Chu Chung (12551592)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

miR-96 binds to the second predicted binding site (96.2) in the 3'UTR of FOXO1 to decrease the protein level. by Benedikta S. Haflidadóttir (245718)

A 59-year-old male with a subacute atherosclerotic infarction nine days after the onset. by Daichi Momosaka (6160418)

The percentages of Th1 and Th17 cells are increased in patients with AECOPD, while the percentage of Th2 cells is decreased in patients with SCOPD. by Ming-Qiang Zhang (646091)

smPPARγOE decreased the transcripts of aortic smooth muscle contractile proteins and the smooth muscle transcriptional co-activator, myocardin. by Jennifer M. Kleinhenz (811618)

Panobinostat decreases proliferation and viability and induces apoptosis independent of H3.3-K27M status <i>in vitro</i>. by Tammy Hennika (3615302)

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Subjects:

Longitudinal associations between baseline CVR and 2 years changes in BDI-II score in participants with a BDI-II score <18 in the PREDIMED-PLUS trial at baseline. by Sandra Martín-Peláez (11353470)

Subjects:

Association between cardiovascular risk and a) depressive status (BDI-II ≥18) and b) BDI-II score, in the PREDIMED-PLUS trial, stratified by CVR factors, at baseline. by Sandra Martín-Peláez (11353470)

Subjects:

Association between CVR components^b'*' and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Subjects:

Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

Subjects:

Proteins from FY26 EVs, CFT073 EVs, and CBE59 EVs identified with a label-free approach. by Min Jiang (56794)

Common definitions and criteria for metabolic syndrome. by Junyin Pan (20700411)

Subjects:

Ectopic expression of <i>GsCML27</i> in <i>Arabidopsis</i> enhanced bicarbonate tolerance, but decreased salt and osmotic tolerance. by Chao Chen (195669)